Robert Sosnowski
Keine laufenden Positionen mehr
Profil
Robert Edward Sosnowski founded Dexgen Pharmaceuticals, Inc. in 2000, where he worked as President & Chief Executive Officer.
Mr. Sosnowski also formerly worked at Algos Pharmaceutical Corp., as Vice President-Sales & Marketing and Cyclacel Pharmaceuticals, Inc., as Vice President-Sales & Marketing in 2012.
Mr. Sosnowski received his undergraduate degree in 1980 from the University of Connecticut.
Ehemalige bekannte Positionen von Robert Sosnowski
| Unternehmen | Position | Ende |
|---|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Vertrieb & Marketing | 30.06.2012 |
Algos Pharmaceutical Corp.
 Algos Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Part of Endo International Plc, Algos Pharmaceutical Corp. develops and makes pain management products including narcotic drugs. The company is based in Neptune, NJ. Algos Pharmaceutical was acquired by Endo Health Solutions, Inc. on July 17, 2000 for $243.89 million. | Vertrieb & Marketing | - |
| Dexgen Pharmaceuticals, Inc. | Gründer | - |
Ausbildung von Robert Sosnowski
| University of Connecticut | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Algos Pharmaceutical Corp.
Algos Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Part of Endo International Plc, Algos Pharmaceutical Corp. develops and makes pain management products including narcotic drugs. The company is based in Neptune, NJ. Algos Pharmaceutical was acquired by Endo Health Solutions, Inc. on July 17, 2000 for $243.89 million. | Health Technology |
| Dexgen Pharmaceuticals, Inc. |
